Impact of administering cardiac medication to small-breed dogs with preclinical myxomatous mitral valve disease on survival after congestive heart failure onset
Myxomatous mitral valve disease (MMVD) is the most common cardiovascular disease in small-breed dogs, and some affected dogs develop congestive heart failure (CHF). Although pimobendan is recommended to delay the onset of CHF, its effect on survival following CHF onset development remains unclear. T...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis Group
2025-12-01
|
| シリーズ: | Veterinary Quarterly |
| 主題: | |
| オンライン･アクセス: | https://www.tandfonline.com/doi/10.1080/01652176.2025.2560412 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|